Effects of Lobeglitazone, a New Thiazolidinedione, on Osteoblastogenesis and Bone Mineral Density in Mice

BACKGROUND: Bone strength is impaired in patients with type 2 diabetes mellitus despite an increase in bone mineral density (BMD). Thiazolidinedione (TZD), a peroxisome proliferator activated receptor γ agonist, promotes adipogenesis, and suppresses osteoblastogenesis. Therefore, its use is associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyoung Min, Jin, Hyun-Jin, Lee, Seo Yeon, Maeng, Hyo Jin, Lee, Gha Young, Oh, Tae Jung, Choi, Sung Hee, Jang, Hak Chul, Lim, Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620037/
https://www.ncbi.nlm.nih.gov/pubmed/28956370
http://dx.doi.org/10.3803/EnM.2017.32.3.389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620037/
https://www.ncbi.nlm.nih.gov/pubmed/28956370
http://dx.doi.org/10.3803/EnM.2017.32.3.389

Ejemplares similares